European Biotech Acquisition Corp. (EBAC) Research

European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.

Market snapshot

Symbol
EBAC
Price
$11.19
Day change
-4.44%
Market cap
$183.5M
P/E ratio
40.73x
52-week range
9.282-14.1
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • AP Acquisition Corp. (APCA)
  • Bridgetown Holdings Limited (BTWN)
  • Direxion Daily COIN Bull 2X ETF (CONX)
  • G Squared Ascend II Inc. (GSQB)
  • Parabellum Acquisition Corp. (PRBM)
  • SK Growth Opportunities Corporation (SKGR)
  • Tristar Acquisition I Corp. (TRIS)
  • Zapata Quantum, Inc. (ZPTA)

Recent insider activity

  • Kleijwegt Martijn — trade (3400000 shares) on 2021-03-15

Open European Biotech Acquisition Corp. (EBAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.